Steris (STE) FCF Payout Ratio Growth (1y) (2019 - 2026)
Steris (STE) FCF Payout Ratio Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.67 Bn | 194.07 Bn | 7.27 Bn | -16.90% |
| 2 | Stryker | 129.56 Bn | 126.09 Bn | 4.50 Bn | -8.00% |
| 3 | Medtronic | 119.87 Bn | 110.65 Bn | 6.41 Bn | 0.45% |
| 4 | Boston Scientific | 73.80 Bn | 73.27 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.66 Bn | 48.41 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.56 Bn | 32.61 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn | -88.24% |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | -11.29% |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 27.54% |
| 10 | Zimmer Biomet Holdings | 19.35 Bn | 18.94 Bn | 1.54 Bn | -18.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.54% |
| Mar 31, 2026 | 215.07% |
| Dec 31, 2025 | -353.55% |
| Sep 30, 2025 | -18.67% |
| Jun 30, 2025 | -34.48% |
| Mar 31, 2025 | -169.93% |
| Dec 31, 2024 | 141.31% |
| Sep 30, 2024 | -53.77% |
| Jun 30, 2024 | 21.42% |
| Dec 31, 2023 | 28.76% |
| Sep 30, 2023 | -63.34% |
| Jun 30, 2023 | -41.72% |
| Dec 31, 2022 | -397.46% |
| Sep 30, 2022 | 390.05% |
| Jun 30, 2022 | -55.38% |
| Mar 31, 2022 | -42.95% |
| Dec 31, 2021 | 17.33% |
| Sep 30, 2021 | 57.67% |
| Jun 30, 2021 | 77.88% |
| Mar 31, 2021 | -29.35% |